Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:GTH

Genetron (GTH) Stock Price, News & Analysis

Genetron logo

About Genetron Stock (NASDAQ:GTH)

Key Stats

Today's Range
$4.02
$4.05
50-Day Range
$3.85
$4.03
52-Week Range
$2.08
$4.05
Volume
412,600 shs
Average Volume
51,662 shs
Market Capitalization
$127.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Genetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China. It offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. The company also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. Genetron Holdings Limited was founded in 2013 and is headquartered in Beijing, the People's Republic of China.

Receive GTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genetron and its competitors with MarketBeat's FREE daily newsletter.

GTH Stock News Headlines

Tesla Execs are Freaking Out
It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.
Genetron (NASDAQ: GTH)
Genetron Holdings Ltd. ADR
See More Headlines

GTH Stock Analysis - Frequently Asked Questions

Genetron Holdings Limited (NASDAQ:GTH) posted its quarterly earnings results on Sunday, May, 23rd. The company reported ($0.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by $0.30. The company had revenue of $14.05 million for the quarter.
Read the conference call transcript
.

Genetron's stock reverse split on Thursday, October 26th 2023. The 1-3 reverse split was announced on Thursday, October 26th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 26th 2023. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

Genetron (GTH) raised $162 million in an initial public offering (IPO) on Friday, June 19th 2020. The company issued 13,000,000 shares at a price of $11.50-$13.50 per share. Credit Suisse and CICC acted as the underwriters for the IPO and BTIG and Canaccord Genuity were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genetron investors own include NVIDIA (NVDA), ServiceNow (NOW), Broadcom (AVGO), Adobe (ADBE), CrowdStrike (CRWD), Meta Platforms (META) and Arista Networks (ANET).

Company Calendar

Last Earnings
5/23/2021
Today
11/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
NASDAQ:GTH
Fax
N/A
Employees
993
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$94.34 million
Book Value
$2.63 per share

Miscellaneous

Free Float
N/A
Market Cap
$127.43 million
Optionable
Not Optionable
Beta
0.51
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

This page (NASDAQ:GTH) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners